PCDSOS outperforms existing tools in adult bronchiectasis, providing a cost-effective screening strategy to identify patients requiring further PCD diagnostic testing-critical for preventing irreversible lung damage and guiding genetic counseling.
Zhou et al. (Tue,) studied this question.